FDA official announcements or press releases

Mark Cuban's Cost Plus Drug Company to Import Penicillin Amid US Shortage, Reducing Price from $500 to $15

Jul 17, 2024, 07:00 PM

Mark Cuban's Cost Plus Drug Company has received temporary approval from the U.S. Food and Drug Administration (FDA) to import and distribute penicillin in the United States. The company will import Penicillin G Benzathine, a crucial medication used to treat syphilis, which is currently in short supply in the country. The price of the drug has been drastically reduced from $500 to $15, making it more accessible to healthcare providers and patients. This initiative aims to address the shortage and affordability issues, particularly benefiting babies born with syphilis and HIV patients who previously could not obtain or afford the medication. The approval was granted on Wednesday.